<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05062668</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_0191</org_study_id>
    <nct_id>NCT05062668</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma</brief_title>
  <acronym>EII</acronym>
  <official_title>Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Hospital Saint Quentin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated&#xD;
      treatment is to lower intraocular pressure (IOP). It is the 2nd leading cause of blindness&#xD;
      worldwide. The iStent® inject and inject W is an implantable device that is part of a new&#xD;
      entity of so-called minimally invasive glaucoma surgery whose goal is to lower IOP with&#xD;
      minimal tissue disruption in order to avoid the complications of conventional glaucoma&#xD;
      surgery. This surgery is used in conjunction with cataract surgery in France. The primary&#xD;
      objective is to study the 1-year efficacy and safety of combined cataract and iStent inject&#xD;
      and inject W in the management of POAG in an observational, retrospective, controlled study&#xD;
      of a cohort of POAG patients undergoing cataract surgery only.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>variation of IOP (in mmHg) between both groups</measure>
    <time_frame>1 year</time_frame>
    <description>variation of IOP (in mmHg) between the istent and cataract operation group versus the cataract operation only group</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>POAG</condition>
  <condition>MIGS</condition>
  <arm_group>
    <arm_group_label>iStent</arm_group_label>
    <description>POAG patient operated at the CHU of Amiens or the CH of Saint-Quentin of a combined cataract and iStent inject or inject W surgery from January 2018 to September 2020.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cataract only</arm_group_label>
    <description>POAG patients operated only on cataract from January 2018 to September 2020.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cataract operation and istent</intervention_name>
    <description>a cataract operation and the placement of one or two iStent inject or inject W at the same time</description>
    <arm_group_label>iStent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cataract operation only</intervention_name>
    <description>Patients have a classic postoperative treatment after cataract.</description>
    <arm_group_label>cataract only</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        There are two groups, the first group is the iStent group. The investigators took all the&#xD;
        POAG patients operated at the CHU of Amiens or the CH of Saint-Quentin of a combined&#xD;
        cataract and iStent inject or inject W surgery from January 2018 to September 2020. The&#xD;
        second group is the control group of POAG patients operated only on cataract during the&#xD;
        same period.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient who have undergone combined phacoemulsification surgery and insertion of at&#xD;
             least one iStent® for chronic open-angle glaucoma in the ophthalmology department of&#xD;
             the Amiens University Hospital or the Saint-Quentin University Hospital (iStent®&#xD;
             group).&#xD;
&#xD;
          -  patient who have undergone simple phacoemulsification surgery in a patient with&#xD;
             chronic open-angle glaucoma in the ophthalmology department of the Amiens University&#xD;
             Hospital (control group).&#xD;
&#xD;
          -  patient with Chronic open-angle glaucoma confirmed by gonioscopic examination, visual&#xD;
             field, optical coherence tomography of the optic nerve, fundus examination, pachymetry&#xD;
             and intraocular air pressure and/or applanation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute angle closure glaucoma,&#xD;
&#xD;
          -  chronic angle closure glaucoma,&#xD;
&#xD;
          -  uveitic glaucoma,&#xD;
&#xD;
          -  traumatic glaucoma,&#xD;
&#xD;
          -  exfoliative glaucoma.&#xD;
&#xD;
          -  Previous filtering surgery on the operated eye.&#xD;
&#xD;
          -  Intraoperative complication.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin Jany, MD</last_name>
    <phone>03 22 08 92 19</phone>
    <email>jany.benjamin@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Jany, MD</last_name>
      <phone>03 22 08 92 19</phone>
      <email>jany.benjamin@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>POAG</keyword>
  <keyword>iStent inject</keyword>
  <keyword>MIGS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

